Apolipoprotein C-III in patients with systemic lupus erythematosus

Abstract Background Systemic lupus erythematosus (SLE) has been associated with atherosclerotic cardiovascular disease (CV) and an altered lipid profile. High levels of apolipoprotein C-III (ApoC3) are associated with elevated triglyceride levels and an increased risk of CV. In the present study, we...

Full description

Saved in:
Bibliographic Details
Main Authors: Candelaria Martín-González, Carmen Ferrer-Moure, Juan Carlos Quevedo-Abeledo, Antonia de Vera-González, Alejandra González-Delgado, Julio Sánchez-Martín, Miguel Á. González-Gay, Iván Ferraz-Amaro
Format: Artigo
Language:Inglês
Published: BMC 2022-05-01
Series:Arthritis Research & Therapy
Subjects:
Systemic lupus erythematosus
Apolipoprotein C3
Online Access:https://doi.org/10.1186/s13075-022-02793-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items